diabetes mellitus
Explore 2 research publications tagged with this keyword
Publications Tagged with "diabetes mellitus"
2 publications found
2026
1 publicationOrforglipron: An Integrated Review of an Oral Small-Molecule GLP-1 Receptor Agonist
Background: Obesity and type 2 diabetes mellitus are chronic metabolic disorders with substantial cardiovascular, renal and metabolic consequences. Many established glucagon-like peptide-1 receptor agonists are peptide medicines administered by injection, creating practical barriers for patients. Orforglipron is an orally active, nonpeptide small-molecule glucagon-like peptide-1 receptor agonist developed to provide incretin-based metabolic efficacy without injections. Methods: An integrated review was prepared from two supplied 2026 sources: a Drug of the Month article emphasizing medicinal chemistry, receptor binding and regulatory milestones, and a comprehensive review synthesizing pharmacology, pharmacokinetics, clinical efficacy, safety and future directions. Findings were organized descriptively across structure, mechanism, pharmacokinetics, efficacy and tolerability. Results: Orforglipron activates the glucagon-like peptide-1 receptor through a predominantly Gs-biased, transmembrane allosteric binding mode, increasing cyclic adenosine monophosphate signalling, enhancing glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying and promoting satiety. Phase 2–3 evidence showed clinically meaningful reductions in glycated haemoglobin and dose-dependent weight loss of approximately 12–15% at higher doses in obesity. The principal tolerability limitation was gastrointestinal adverse effects, concentrated during dose escalation. Conclusion: Orforglipron represents a significant advancement in oral incretin pharmacotherapy. Long-term comparative effectiveness, cardiovascular and renal outcomes, real-world persistence and evidence in underrepresented populations remain important research gaps.
2017
1 publicationA Study on Prescribing Pattern of Antidiabetic Drugs in Type-2 Diabetic Patients In A Tertiary Care Teaching Hospital
ABSTRACTPrescribing pattern monitoring studies are a tool for assessing the prescribing, dispensing and distribution of medicines. The main aim of this study is to facilitate rational use of medicines. Diabetes is a metabolic disorder characterized by the existence of hyperglycaemia due to malfunctioning insulin secretion, insulin action or both. The main aim of this study is to study the prescribing pattern of anti-diabetic drugs in a Type-II diabetes mellitus in a tertiary care teaching hospital. This Prospective observational study performed for a period of 6 months in general medicine department Rajiv Gandhi Institute of Medical sciences. A total 320(100%) patients were recruited under inclusion criteria upon taking of ICF based on inclusion and exclusion criteria. In this study we found a higher incidence in age group of 45-65 years. Mean age of patients came out to be 57.36 ± 8.80 years. Average number of drugs per prescription was 3.99 because of polypharmacy practice in diabetic patients. Biguanides and Sulfonylureas are the most commonly prescribed antidiabetic drugs that were in line with other studies. Among biguanides metformin was most commonly prescribed drug. Maintaining better glycemic control is a therapeutic goal for Type 2 DM patients, which can reduce the frequency of complications and thereby improves quality of life. A strong conclusion of this study highlights the necessity for patient education and counselling on usage of antidiabetic and associated drugs, regular checkups of blood glucose and glycosylated haemoglobin (HbA1c) levels, dietary changes with low calorie food, and rectification of diabetic problems. Keywords: Prescribing pattern, diabetes mellitus, rational use of drugs, better patient care.
